92
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mutations in the Cholesterol Transporter Gene ABCA5 Are Associated with Excessive Hair Overgrowth

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inherited hypertrichoses are rare syndromes characterized by excessive hair growth that does not result from androgen stimulation, and are often associated with additional congenital abnormalities. In this study, we investigated the genetic defect in a case of autosomal recessive congenital generalized hypertrichosis terminalis (CGHT) (OMIM135400) using whole-exome sequencing. We identified a single base pair substitution in the 5′ donor splice site of intron 32 in the ABC lipid transporter gene ABCA5 that leads to aberrant splicing of the transcript and a decrease in protein levels throughout patient hair follicles. The homozygous recessive disruption of ABCA5 leads to reduced lysosome function, which results in an accumulation of autophagosomes, autophagosomal cargos as well as increased endolysosomal cholesterol in CGHT keratinocytes. In an unrelated sporadic case of CGHT, we identified a 1.3 Mb cryptic deletion of chr17q24.2-q24.3 encompassing ABCA5 and found that ABCA5 levels are dramatically reduced throughout patient hair follicles. Collectively, our findings support ABCA5 as a gene underlying the CGHT phenotype and suggest a novel, previously unrecognized role for this gene in regulating hair growth.

          Author Summary

          Inherited hypertrichoses represent a group of hair overgrowth syndromes that are extremely rare in humans and have remained an area of great interest to evolutionary geneticists since they are considered to be recurrences of an ancestral phenotype. These syndromes often present with additional congenital abnormalities including bone, heart and dental defects; thus, it is crucial to identify the mechanisms and genes underlying the pathology. Copy number variants (CNVs) have previously been reported in several cases of congenital generalized hypertrichosis terminalis (CGHT) with a minimal overlapping region of 555 kb encompassing four genes. However, no point mutations in these or any other single genes have been described to underlie the CGHT phenotype. In this study, we report the first loss-of-function mutation in an ABC transporter, ABCA5 and identified an additional copy number variant in a separate case that lies within the minimal common region. We found high levels of ABCA5 expression in both epithelial and mesenchymal compartments of human and mouse hair follicles, and in CGHT patients, this expression is significantly reduced or completely lost. ABCA5 is a lysosomal protein, and its loss-of-function compromises the integrity of lysosomes and leads to an intra-endolysosomal accumulation of cholesterol. Importantly, our findings support a novel role for ABCA5 in regulating hair growth.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          ABC transporters in cancer: more than just drug efflux pumps.

          Multidrug transporter proteins are best known for their contributions to chemoresistance through the efflux of anticancer drugs from cancer cells. However, a considerable body of evidence also points to their importance in cancer extending beyond drug transport to fundamental roles in tumour biology. Currently, much of the evidence for these additional roles is correlative and definitive studies are needed to confirm causality. We propose that delineating the precise roles of these transporters in tumorigenesis and treatment response will be important for the development of more effective targeted therapies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Improved splice site detection in Genie.

            We present an improved splice site predictor for the genefinding program Genie. Genie is based on a generalized Hidden Markov Model (GHMM) that describes the grammar of a legal parse of a multi-exon gene in a DNA sequence. In Genie, probabilities are estimated for gene features by using dynamic programming to combine information from multiple content and signal sensors, including sensors that integrate matches to homologous sequences from a database. One of the hardest problems in genefinding is to determine the complete gene structure correctly. The splice site sensors are the key signal sensors that address this problem. We replaced the existing splice site sensors in Genie with two novel neural networks based on dinucleotide frequencies. Using these novel sensors, Genie shows significant improvements in the sensitivity and specificity of gene structure identification. Experimental results in tests using a standard set of annotated genes showed that Genie identified 86% of coding nucleotides correctly with a specificity of 85%, versus 80% and 84% in the older system. In further splice site experiments, we also looked at correlations between splice site scores and intron and exon lengths, as well as at the effect of distance to the nearest splice site on false positive rates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.

              Numerous disease-associated point mutations exert their effects by disrupting the activity of exonic splicing enhancers (ESEs). We previously derived position weight matrices to predict putative ESEs specific for four human SR proteins. The score matrices are part of ESEfinder, an online resource to identify ESEs in query sequences. We have now carried out a refined functional SELEX screen for motifs that can act as ESEs in response to the human SR protein SF2/ASF. The test BRCA1 exon under selection was internal, rather than the 3'-terminal IGHM exon used in our earlier studies. A naturally occurring heptameric ESE in BRCA1 exon 18 was replaced with two libraries of random sequences, one seven nucleotides in length, the other 14. Following three rounds of selection for in vitro splicing via internal exon inclusion, new consensus motifs and score matrices were derived. Many winner sequences were demonstrated to be functional ESEs in S100-extract-complementation assays with recombinant SF2/ASF. Motif-score threshold values were derived from both experimental and statistical analyses. Motif scores were shown to correlate with levels of exon inclusion, both in vitro and in vivo. Our results confirm and extend our earlier data, as many of the same motifs are recognized as ESEs by both the original and our new score matrix, despite the different context used for selection. Finally, we have derived an increased specificity score matrix that incorporates information from both of our SF2/ASF-specific matrices and that accurately predicts the exon-skipping phenotypes of deleterious point mutations.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Genet
                PLoS Genet
                plos
                plosgen
                PLoS Genetics
                Public Library of Science (San Francisco, USA )
                1553-7390
                1553-7404
                May 2014
                15 May 2014
                : 10
                : 5
                : e1004333
                Affiliations
                [1 ]Department of Genetics and Development, Columbia University, New York, New York, United States of America
                [2 ]Department of Dermatology, Columbia University, New York, New York, United States of America
                [3 ]Department of Pediatrics, Columbia University Medical Center, New York, New York, United States of America
                [4 ]Department of Pathology and Cell Biology, Columbia University, New York, New York, United States of America
                [5 ]Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America
                [6 ]St. Luke's-Roosevelt Hospital Center, New York, New York, United States of America
                [7 ]Centro Dermatológico Pascua, Mexico City, Mexico
                [8 ]New York Presbyterian Hospital, New York, New York, United States of America
                [9 ]Basic Science, Universidad de Monterrey, Nueva Leon, Mexico
                Max-Delbrück-Center for Molecular Medicine, Germany
                Author notes

                The authors have declared that no competing interests exist.

                Conceived and designed the experiments: GMD AMC. Performed the experiments: GMD. Analyzed the data: GMD CD GDP. Contributed reagents/materials/analysis tools: CD GDP. Wrote the paper: GMD. Performed autophagy analysis and filipin staining: CD. Performed experiments and analyses in sporadic CGHT case: GMD MKu VJ KAF MKi MTS AS AV DW BL. Performed clinical evaluations of the patients and provided clinical photos: KAY HF NS LR LDLC JCSA.

                Article
                PGENETICS-D-13-02050
                10.1371/journal.pgen.1004333
                4022463
                24831815
                de43fb07-667c-4048-990e-d2daf9b6775c
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 31 July 2013
                : 7 March 2014
                Page count
                Pages: 15
                Funding
                This work was supported by NIH/NIAMS Grant P30AR44535 ( http://www.niams.nih.gov/) GMD was supported by Columbia University Department of Genetics and Development Training Grant (T32GM007088) and is now supported by an F31 fellowship (NIH/NIDCR; F31 DE023472-01A1). This work was supported in part by the Skin Disease Research Center in the Department of Dermatology at Columbia University (USPHS P3044345) and the NIH/NIAMS Grant R01AR44924 (to AMC). ( http://www.niams.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Biotechnology
                Genetic Engineering
                Genetics
                Cytogenetics
                Gene Expression
                Genetics of Disease
                Heredity
                Human Genetics
                Molecular Genetics
                Mutation

                Genetics
                Genetics

                Comments

                Comment on this article